Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLIC: hLF1-11 in Candidaemia
NCT00509834Phase 2Withdrawn
- Sponsor
- AM-Pharma
- Start
- Jul 2008
- Primary completion
- Jan 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of human lactoferrin peptide 1-11 in candidemia, sponsored by AM-Pharma. Planned start Jul 2008; status: withdrawn.
02
Drugs
human lactoferrin peptide 1-11
03
Conditions
candidemia
Beyond the preview
Go deeper on NCT00509834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00509834.